OVID
Ovid Therapeutics Inc

5,907
Loading...
Loading...
News
all
press releases
Ovid Therapeutics (OVID) Reports Q2 Loss, Beats Revenue Estimates
Ovid Therapeutics (OVID) delivered earnings and revenue surprises of +62.50% and +4,225.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·28d ago
News Placeholder
More News
News Placeholder
Ovid Therapeutics (OVID) Reports Q1 Loss, Tops Revenue Estimates
Zacks·4mo ago
News Placeholder
Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
chainwire·4mo ago
News Placeholder
Expert Outlook: Ovid Therapeutics Through The Eyes Of 7 Analysts
Latest Ratings for OVID DateFirmActionFromTo Aug 2021CitigroupMaintainsNeutral Apr 2021Cantor FitzgeraldDowngradesOverweightNeutral Dec 2020CitigroupDowngradesBuyNeutral View More Analyst...
Benzinga·1y ago
News Placeholder
H.C. Wainwright Reaffirms Their Buy Rating on Ovid Therapeutics (OVID)
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Ovid Therapeutics (OVID Research Report), with a price...
TipRanks Financial Blog·1y ago
News Placeholder
Buy Rating Affirmed for Ovid Therapeutics Amid Promising Pipeline and Stable Financial Outlook
TD Cowen analyst Ritu Baral has maintained their bullish stance on OVID stock, giving a Buy rating today. Ritu Baral has given his Buy rating due t...
TipRanks Financial Blog·1y ago
News Placeholder
Buy Rating Affirmed for Ovid Therapeutics on Advisory Expansion and Promising Epilepsy Drug Prospects
Analyst Ram Selvaraju of H.C. Wainwright reiterated a Buy rating on Ovid Therapeutics (OVID Research Report), retaining the price target of $3.00...
TipRanks Financial Blog·1y ago
News Placeholder
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...
PR Newswire·1y ago
News Placeholder
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...
PR Newswire·1y ago
News Placeholder
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...
PR Newswire·1y ago

Latest OVID News

View

Advertisement. Remove ads.

Advertisement. Remove ads.